市場調查報告書
商品編碼
1263928
血漿分餾市場:趨勢,機會及競爭分析(2023年~2028年)Plasma Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-2028] |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球血漿分餾的市場規模,預計2023年至2028年以7%的年複合成長率擴大,至2028年達到427億美元。這個市場的主要促進因素,是老年人口增加,呼吸疾病盛行率的上升,各種治療用途的免疫球蛋白的使用增加。
本報告提供全球血漿分餾市場相關調查,市場概要,以及各產品,各手法,各用途,各最終用途產業,各地區趨勢,及加入此市場的主要企業簡介等資訊。
Plasma Fractionation Market Trends and Forecast
The future of the plasma fractionation market looks promising with opportunities in hospitals & clinics and clinical research. The global plasma fractionation market is expected to reach an estimated $42.7 billion by 2028 with a CAGR of 7% from 2023 to 2028. The major drivers for this market are rising geriatric population, increasing prevalence of respiratory diseases, and growing use of immunoglobulin in different therapeutic applications.
Plasma Fractionation Market by Product, Method, Application, End Use Industry, and Region
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Plasma Fractionation Market by Segments
Plasma Fractionation Market by Segment
Plasma Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Albumin
Immunoglobulins
Intravenous immunoglobulins
Subcutaneous immunoglobulins
Others
Coagulation Factors
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrates
Fibrinogen Concentrates
Others
Protease Inhibitors
Others
Plasma Fractionation Market by Method [Value ($B) Shipment Analysis from 2017 to 2028]:
Centrifugation
Depth Filtration
Chromatography
Others
Plasma Fractionation Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Neurology
Hematology
Oncology
Immunology
Pulmonology
Others
Plasma Fractionation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
Hospitals & Clinics
Clinical Research
Others
Plasma Fractionation Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of Plasma Fractionation Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, plasma fractionation companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the plasma fractionation companies profiled in this report include-
Grifols
CSL
Takeda Pharmaceutical
Octapharma
Kedrion
Plasma Fractionation Market Insights
Lucintel forecasts that immunoglobulin will remain the largest product segment over the forecast period due to the increasing prevalence of infections and disorders and its extensive use in treatment, diagnosis, and administration of metabolic diseases.
Hospitals & clinics are expected to remain the largest end use industry segment due to the extensive use of plasma fractionation among hospitals and clinics to treat various diseases.
North America will remain the largest region due to an increase in the quantity of plasma collection facilities, rise in the demand for immunoglobulin, and growing number of elderly people with hereditary diseases in the region.
Features of the Plasma Fractionation Market
Market Size Estimates: Plasma fractionation market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: Plasma fractionation market size by various segments, such as product, method, application, end use industry, and region
Regional Analysis: Plasma fractionation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different products, methods, applications, end use industries, and regions for the plasma fractionation market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the plasma fractionation market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the plasma fractionation market size?
Answer: The global plasma fractionation market is expected to reach an estimated $42.7 billion by 2028.
Q2. What is the growth forecast for plasma fractionation market?
Answer: The global plasma fractionation market is expected to grow with a CAGR of 7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the plasma fractionation market?
Answer: The major drivers for this market are rising geriatric population, increasing prevalence of respiratory diseases, and growing use of immunoglobulin in different therapeutic applications.
Q4. What are the major segments for plasma fractionation market?
Answer: The future of the plasma fractionation market looks promising with opportunities in hospitals & clinics and clinical research.
Q5. Who are the key plasma fractionation companies?
Answer: Some of the key plasma fractionation companies are as follows:
Grifols
CSL
Takeda Pharmaceutical
Octapharma
Kedrion
Q6. Which plasma fractionation segment will be the largest in the future?
Answer: Lucintel forecasts that immunoglobulin will remain the largest product segment over the forecast period due to the increasing prevalence of infections and disorders and its extensive use for the treatment, diagnosis, and administration of metabolic diseases.
Q7. In plasma fractionation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increase in quantity of plasma collection facilities, rise in the demand for immunoglobulin, and growing number of elderly people with hereditary diseases in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.